Study of SBRT/Olaparib Followed by Pembrolizumab/Olaparib in Gastric Cancers
Clinical trial NCT05379972 · COMPLETED
Trial details
- NCT number
- NCT05379972
- Sponsor
- University of Colorado, Denver
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-12
- Primary completion
- 2025-02-24
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.